Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 449

1.

Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.

Morgan JA, Brewer RJ, Nemeh HW, Murthy R, Williams CT, Lanfear DE, Tita C, Paone G.

ASAIO J. 2012 Nov-Dec;58(6):574-7. doi: 10.1097/MAT.0b013e31826e4267.

PMID:
23103696
2.

Impact of continuous-flow left ventricular assist device support on right ventricular function.

Morgan JA, Paone G, Nemeh HW, Murthy R, Williams CT, Lanfear DE, Tita C, Brewer RJ.

J Heart Lung Transplant. 2013 Apr;32(4):398-403. doi: 10.1016/j.healun.2012.12.018. Epub 2013 Feb 9.

PMID:
23402946
3.

Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices.

Maltais S, Topilsky Y, Tchantchaleishvili V, McKellar SH, Durham LA, Joyce LD, Daly RC, Park SJ.

J Thorac Cardiovasc Surg. 2012 Jun;143(6):1370-6. doi: 10.1016/j.jtcvs.2011.07.014. Epub 2011 Aug 11.

PMID:
21839483
4.

Effects of the HeartMate II left ventricular assist device as observed by serial echocardiography.

Chapman CB, Allana S, Sweitzer NK, Kohmoto T, Murray M, Murray D, Johnson M, Rahko PS.

Echocardiography. 2013 May;30(5):513-20. doi: 10.1111/echo.12100. Epub 2013 Jan 11.

5.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

PMID:
20447659
6.

Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling.

Foster E, Kwan D, Feldman T, Weissman NJ, Grayburn PA, Schwartz A, Rogers JH, Kar S, Rinaldi MJ, Fail PS, Hermiller J, Whitlow PL, Herrmann HC, Lim DS, Glower DD; EVEREST Investigators.

Circ Cardiovasc Imaging. 2013 Jul;6(4):522-30. doi: 10.1161/CIRCIMAGING.112.000098. Epub 2013 Apr 30.

7.

Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.

Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG; UCAR (Utah Cardiac Recovery Program) Investigators.

J Am Coll Cardiol. 2013 May 14;61(19):1985-94. doi: 10.1016/j.jacc.2013.01.072. Epub 2013 Mar 14.

8.

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices.

John R, Liao K, Kamdar F, Eckman P, Boyle A, Colvin-Adams M.

J Thorac Cardiovasc Surg. 2010 Aug;140(2):447-52. doi: 10.1016/j.jtcvs.2010.03.006.

PMID:
20435321
9.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
10.

Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation.

Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, Boersma E, Dion RA.

Eur J Cardiothorac Surg. 2005 May;27(5):847-53.

PMID:
15848325
11.

Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy.

De Bonis M, Lapenna E, Verzini A, La Canna G, Grimaldi A, Torracca L, Maisano F, Alfieri O.

Ann Thorac Surg. 2008 Mar;85(3):932-9. doi: 10.1016/j.athoracsur.2007.11.021.

PMID:
18291174
12.

Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices.

John R, Naka Y, Park SJ, Sai-Sudhakar C, Salerno C, Sundareswaran KS, Farrar DJ, Milano CA.

J Thorac Cardiovasc Surg. 2014 Feb;147(2):581-9; discussion 589. doi: 10.1016/j.jtcvs.2013.10.024.

PMID:
24418362
13.

Influence of longer term left ventricular assist device support on valvular regurgitation.

Holman WL, Bourge RC, Fan P, Kirklin JK, Pacifico AD, Nanda NC.

ASAIO J. 1994 Jul-Sep;40(3):M454-9.

PMID:
8555557
14.

Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.

Vatta M, Stetson SJ, Jimenez S, Entman ML, Noon GP, Bowles NE, Towbin JA, Torre-Amione G.

J Am Coll Cardiol. 2004 Mar 3;43(5):811-7.

15.

Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.

Gupta S, Woldendorp K, Muthiah K, Robson D, Prichard R, Macdonald PS, Keogh AM, Kotlyar E, Jabbour A, Dhital K, Granger E, Spratt P, Jansz P, Hayward CS.

Heart Lung Circ. 2014 Oct;23(10):963-9. doi: 10.1016/j.hlc.2014.04.259. Epub 2014 Jun 3.

PMID:
24973864
16.

Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.

Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, Shahzad K, Iwata S, Homma S, Takayama H, Naka Y, Jorde U, Farr M, Mancini DM, Schulze PC.

Circ Heart Fail. 2011 Sep;4(5):546-53. doi: 10.1161/CIRCHEARTFAILURE.111.962142. Epub 2011 Jul 15.

17.

Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.

Kitada S, Kato TS, Thomas SS, Conwell SD, Russo C, Di Tullio MR, Farr M, Schulze PC, Uriel N, Jorde UP, Takayama H, Naka Y, Homma S, Mancini DM.

J Heart Lung Transplant. 2013 Sep;32(9):897-904. doi: 10.1016/j.healun.2013.06.004. Epub 2013 Jul 11.

18.

Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices.

Thohan V, Stetson SJ, Nagueh SF, Rivas-Gotz C, Koerner MM, Lafuente JA, Loebe M, Noon GP, Torre-Amione G.

J Heart Lung Transplant. 2005 May;24(5):566-75.

PMID:
15896754
19.

Uncorrected pre-operative mitral valve regurgitation is not associated with adverse outcomes after continuous-flow left ventricular assist device implantation.

Stulak JM, Tchantchaleishvili V, Haglund NA, Davis ME, Schirger JA, Cowger JA, Shah P, Aaronson KD, Pagani FD, Maltais S.

J Heart Lung Transplant. 2015 May;34(5):718-23. doi: 10.1016/j.healun.2014.11.023. Epub 2014 Dec 8.

PMID:
25697807
20.

Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?

Sabashnikov A, Popov AF, Bowles CT, Mohite PN, Weymann A, Hards R, Hedger M, Wittwer T, Wippermann J, Wahlers T, Schoendube FA, Simon AR.

J Thorac Cardiovasc Surg. 2014 Sep;148(3):1115-21; discussion 1021-2. doi: 10.1016/j.jtcvs.2014.05.063. Epub 2014 Jun 6.

PMID:
25129605
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk